MAELINN CHOW ASSISTANT RESEARCH ANALYST |
MICHAEL MADDEN |
LEGISLATIVE RESEARCH ANALYST HEALTH & HUMAN SERVICES COMMITTEE Telephone: (602) 926-3171 |
ARIZONA STATE SENATE
RESEARCH STAFF
TO: MEMBERS OF THE SENATE
HEALTH & HUMAN SERVICES COMMITTEE
DATE: March 21, 2022
SUBJECT: Strike everything amendment to H.B. 2635, relating to breast implant surgery; informed consent
Purpose
Applies statutory informed consent requirements for cosmetic breast implant surgery to breast implant surgery for reconstructive purposes.
Background
Current statute
requires licensed medical and osteopathic physicians to provide patients
receiving breast implant surgery with the following information prior to
surgery: 1) a description of the risks of breast implants and of the surgical
procedures used in breast implant surgery;
2) manufacturer patient information materials on the implants that will be used
in the surgery, including warning requirements prescribed by the U.S. Food and
Drug Administration (FDA);
3) the informed consent checklist, including information on breast
implant-associated anaplastic large cell lymphoma, breast implant illness and
the National Breast Implant Registry; and
4) information on how the patient can report adverse events associated with
breast implants through the FDA MedWatch Program or any similar program. A
physician must obtain written informed consent for the procedure from the
patient before performing the breast implant surgery. A physician who knowingly
violates the informed consent requirement commits an act of unprofessional
conduct and is subject to disciplinary action.
Breast
implant surgery is the surgical placement of a cosmetic breast implant (A.R.S.
§ 32-3228).
There is no anticipated fiscal impact to the state General Fund associated with this legislation.
Provisions
1. Applies statutory informed consent requirements for cosmetic breast implant surgery to breast implant surgery for reconstructive purposes.
2. Makes technical changes.
3. Becomes effective on the general effective date.